HCFA expands investigation into Gambro's billing practices
This article was originally published in Clinica
Executive Summary
The US government agency investigating the billing operations of Gambro's US laboratory testing is to extend the time-period under examination. The investigations into the Gambro subsidiaries, Gambro Healthcare Laboratory Services and Dialysis Holdings Laboratory Services, will now cover billing activities throughout 1994 and 1995 as well as the original two periods between 1996 and 1998.